vs

Side-by-side financial comparison of ADTRAN Holdings, Inc. (ADTN) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $291.6M, roughly 1.7× ADTRAN Holdings, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -1.2%, a 8.1% gap on every dollar of revenue. On growth, ADTRAN Holdings, Inc. posted the faster year-over-year revenue change (20.1% vs -1.7%). Over the past eight quarters, ADTRAN Holdings, Inc.'s revenue compounded faster (13.5% CAGR vs -0.1%).

Adtran, Inc. is an American fiber networking and telecommunications company headquartered in Huntsville, Alabama. It is a vendor of both residential and enterprise networking equipment, along with administrative software for network management and deployment. Its customers include communications service providers, governments, enterprises and utilities.

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

ADTN vs MD — Head-to-Head

Bigger by revenue
MD
MD
1.7× larger
MD
$493.8M
$291.6M
ADTN
Growing faster (revenue YoY)
ADTN
ADTN
+21.8% gap
ADTN
20.1%
-1.7%
MD
Higher net margin
MD
MD
8.1% more per $
MD
6.8%
-1.2%
ADTN
Faster 2-yr revenue CAGR
ADTN
ADTN
Annualised
ADTN
13.5%
-0.1%
MD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ADTN
ADTN
MD
MD
Revenue
$291.6M
$493.8M
Net Profit
$-3.6M
$33.7M
Gross Margin
39.0%
Operating Margin
1.5%
9.9%
Net Margin
-1.2%
6.8%
Revenue YoY
20.1%
-1.7%
Net Profit YoY
92.2%
10.5%
EPS (diluted)
$-0.02
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADTN
ADTN
MD
MD
Q4 25
$291.6M
$493.8M
Q3 25
$279.4M
$492.9M
Q2 25
$265.1M
$468.8M
Q1 25
$247.7M
$458.4M
Q4 24
$242.9M
$502.4M
Q3 24
$227.7M
$511.2M
Q2 24
$226.0M
$504.3M
Q1 24
$226.2M
$495.1M
Net Profit
ADTN
ADTN
MD
MD
Q4 25
$-3.6M
$33.7M
Q3 25
$-10.3M
$71.7M
Q2 25
$-20.5M
$39.3M
Q1 25
$-11.3M
$20.7M
Q4 24
$-46.1M
$30.5M
Q3 24
$-33.3M
$19.4M
Q2 24
$-49.7M
$-153.0M
Q1 24
$-330.8M
$4.0M
Gross Margin
ADTN
ADTN
MD
MD
Q4 25
39.0%
Q3 25
38.3%
Q2 25
37.3%
Q1 25
38.4%
Q4 24
36.9%
Q3 24
36.5%
Q2 24
36.0%
Q1 24
31.1%
Operating Margin
ADTN
ADTN
MD
MD
Q4 25
1.5%
9.9%
Q3 25
-1.0%
13.8%
Q2 25
-5.0%
12.8%
Q1 25
-1.6%
7.0%
Q4 24
-6.9%
7.8%
Q3 24
-11.5%
6.6%
Q2 24
-17.0%
-31.3%
Q1 24
-153.1%
3.2%
Net Margin
ADTN
ADTN
MD
MD
Q4 25
-1.2%
6.8%
Q3 25
-3.7%
14.5%
Q2 25
-7.7%
8.4%
Q1 25
-4.5%
4.5%
Q4 24
-19.0%
6.1%
Q3 24
-14.6%
3.8%
Q2 24
-22.0%
-30.3%
Q1 24
-146.2%
0.8%
EPS (diluted)
ADTN
ADTN
MD
MD
Q4 25
$-0.02
$0.40
Q3 25
$-0.12
$0.84
Q2 25
$-0.24
$0.46
Q1 25
$-0.14
$0.24
Q4 24
$-0.58
$0.37
Q3 24
$-0.38
$0.23
Q2 24
$-0.63
$-1.84
Q1 24
$-4.20
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADTN
ADTN
MD
MD
Cash + ST InvestmentsLiquidity on hand
$95.7M
$375.2M
Total DebtLower is stronger
$570.5M
Stockholders' EquityBook value
$145.8M
$865.9M
Total Assets
$1.2B
$2.2B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADTN
ADTN
MD
MD
Q4 25
$95.7M
$375.2M
Q3 25
$93.7M
$340.1M
Q2 25
$106.3M
$224.7M
Q1 25
$101.3M
$99.0M
Q4 24
$76.0M
$229.9M
Q3 24
$88.5M
$103.8M
Q2 24
$111.2M
$19.4M
Q1 24
$106.8M
$8.0M
Total Debt
ADTN
ADTN
MD
MD
Q4 25
$570.5M
Q3 25
$577.2M
Q2 25
$583.9M
Q1 25
$590.5M
Q4 24
$597.1M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ADTN
ADTN
MD
MD
Q4 25
$145.8M
$865.9M
Q3 25
$141.6M
$890.7M
Q2 25
$169.6M
$833.8M
Q1 25
$138.9M
$789.2M
Q4 24
$127.0M
$764.9M
Q3 24
$205.6M
$732.5M
Q2 24
$213.6M
$706.5M
Q1 24
$260.8M
$856.2M
Total Assets
ADTN
ADTN
MD
MD
Q4 25
$1.2B
$2.2B
Q3 25
$1.2B
$2.2B
Q2 25
$1.2B
$2.1B
Q1 25
$1.2B
$2.0B
Q4 24
$1.2B
$2.2B
Q3 24
$1.3B
$2.1B
Q2 24
$1.3B
$2.0B
Q1 24
$1.3B
$2.2B
Debt / Equity
ADTN
ADTN
MD
MD
Q4 25
0.66×
Q3 25
0.65×
Q2 25
0.70×
Q1 25
0.75×
Q4 24
0.78×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADTN
ADTN
MD
MD
Operating Cash FlowLast quarter
$42.2M
$114.1M
Free Cash FlowOCF − Capex
$30.6M
FCF MarginFCF / Revenue
10.5%
Capex IntensityCapex / Revenue
4.0%
Cash ConversionOCF / Net Profit
3.39×
TTM Free Cash FlowTrailing 4 quarters
$98.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADTN
ADTN
MD
MD
Q4 25
$42.2M
$114.1M
Q3 25
$12.2M
$137.3M
Q2 25
$32.2M
$137.2M
Q1 25
$43.2M
$-117.5M
Q4 24
$2.4M
$133.0M
Q3 24
$43.3M
$91.8M
Q2 24
$19.9M
$107.0M
Q1 24
$37.9M
$-125.2M
Free Cash Flow
ADTN
ADTN
MD
MD
Q4 25
$30.6M
Q3 25
$4.2M
Q2 25
$27.5M
Q1 25
$35.8M
Q4 24
$-895.0K
Q3 24
$37.1M
Q2 24
$8.4M
Q1 24
$24.4M
FCF Margin
ADTN
ADTN
MD
MD
Q4 25
10.5%
Q3 25
1.5%
Q2 25
10.4%
Q1 25
14.4%
Q4 24
-0.4%
Q3 24
16.3%
Q2 24
3.7%
Q1 24
10.8%
Capex Intensity
ADTN
ADTN
MD
MD
Q4 25
4.0%
Q3 25
2.9%
Q2 25
1.8%
Q1 25
3.0%
Q4 24
1.4%
Q3 24
2.7%
Q2 24
5.1%
Q1 24
6.0%
Cash Conversion
ADTN
ADTN
MD
MD
Q4 25
3.39×
Q3 25
1.91×
Q2 25
3.49×
Q1 25
-5.66×
Q4 24
4.36×
Q3 24
4.72×
Q2 24
Q1 24
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADTN
ADTN

Subscriber Solutions$96.2M33%
Optical Networking Solutions$81.8M28%
Access Aggregation Solutions$64.6M22%
Services And Support$48.9M17%

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

Related Comparisons